131 related articles for article (PubMed ID: 36395646)
1. Novel 1,4,5,6-tetrahydrocyclopenta[d]imidazole-5-carboxamide-based JNK3 inhibitors: Design, synthesis, molecular docking, and therapeutic potential in neurodegenerative diseases.
Jun J; Baek J; Kang D; Moon H; Kim H; Cho H; Hah JM
Eur J Med Chem; 2023 Jan; 245(Pt 1):114917. PubMed ID: 36395646
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel imidazole chemotypes as isoform-selective JNK3 inhibitors for the treatment of Alzheimer's disease.
Jun J; Yang S; Lee J; Moon H; Kim J; Jung H; Im D; Oh Y; Jang M; Cho H; Baek J; Kim H; Kang D; Bae H; Tak C; Hwang K; Kwon H; Kim H; Hah JM
Eur J Med Chem; 2023 Jan; 245(Pt 1):114894. PubMed ID: 36343411
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a Potent and Selective JNK3 Inhibitor with Neuroprotective Effect Against Amyloid β-Induced Neurotoxicity in Primary Rat Neurons.
Jun J; Baek J; Yang S; Moon H; Kim H; Cho H; Hah JM
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681742
[TBL] [Abstract][Full Text] [Related]
4. Discovery of 1-Pyrimidinyl-2-Aryl-4,6-Dihydropyrrolo [3,4-d]Imidazole-5(1
Jang M; Oh Y; Cho H; Yang S; Moon H; Im D; Hah JM
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32131443
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Novel Indazole Chemotypes as Isoform-Selective JNK3 Inhibitors for the Treatment of Parkinson's Disease.
Shuai W; Bu F; Zhu Y; Wu Y; Xiao H; Pan X; Zhang J; Sun Q; Wang G; Ouyang L
J Med Chem; 2023 Jan; 66(2):1273-1300. PubMed ID: 36649216
[TBL] [Abstract][Full Text] [Related]
6. The neuroprotective action of JNK3 inhibitors based on the 6,7-dihydro-5H-pyrrolo[1,2-a]imidazole scaffold.
Graczyk PP; Khan A; Bhatia GS; Palmer V; Medland D; Numata H; Oinuma H; Catchick J; Dunne A; Ellis M; Smales C; Whitfield J; Neame SJ; Shah B; Wilton D; Morgan L; Patel T; Chung R; Desmond H; Staddon JM; Sato N; Inoue A
Bioorg Med Chem Lett; 2005 Nov; 15(21):4666-70. PubMed ID: 16153829
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Evaluation of Diphenyl Conjugated Imidazole Derivatives as Potential Glutaminyl Cyclase Inhibitors for Treatment of Alzheimer's Disease.
Li M; Dong Y; Yu X; Li Y; Zou Y; Zheng Y; He Z; Liu Z; Quan J; Bu X; Wu H
J Med Chem; 2017 Aug; 60(15):6664-6677. PubMed ID: 28700245
[TBL] [Abstract][Full Text] [Related]
8. Novel scaffold evolution through combinatorial 3D-QSAR model studies of two types of JNK3 inhibitors.
Jung H; Aman W; Hah JM
Bioorg Med Chem Lett; 2017 May; 27(10):2139-2143. PubMed ID: 28372912
[TBL] [Abstract][Full Text] [Related]
9. Multistage Screening Reveals 3-Substituted Indolin-2-one Derivatives as Novel and Isoform-Selective c-Jun N-terminal Kinase 3 (JNK3) Inhibitors: Implications to Drug Discovery for Potential Treatment of Neurodegenerative Diseases.
Dou X; Huang H; Li Y; Jiang L; Wang Y; Jin H; Jiao N; Zhang L; Zhang L; Liu Z
J Med Chem; 2019 Jul; 62(14):6645-6664. PubMed ID: 31268308
[TBL] [Abstract][Full Text] [Related]
10. Discovery of 3-alkyl-5-aryl-1-pyrimidyl-1
Oh Y; Jang M; Cho H; Yang S; Im D; Moon H; Hah JM
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):372-376. PubMed ID: 31856610
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of 1H-phenanthro[9,10-d]imidazole derivatives as multifunctional agents for treatment of Alzheimer's disease.
Liu J; Qiu J; Wang M; Wang L; Su L; Gao J; Gu Q; Xu J; Huang SL; Gu LQ; Huang ZS; Li D
Biochim Biophys Acta; 2014 Sep; 1840(9):2886-903. PubMed ID: 24821011
[TBL] [Abstract][Full Text] [Related]
12. Rational modification, synthesis and biological evaluation of 3,4-dihydroquinoxalin-2(1H)-one derivatives as potent and selective c-Jun N-terminal kinase 3 (JNK3) inhibitors.
Dou X; Huang H; Jiang L; Zhu G; Jin H; Jiao N; Zhang L; Liu Z; Zhang L
Eur J Med Chem; 2020 Sep; 201():112445. PubMed ID: 32603981
[TBL] [Abstract][Full Text] [Related]
13. Identification and neuroprotective evaluation of a potential c-Jun N-terminal kinase 3 inhibitor through structure-based virtual screening and in-vitro assay.
Rajan RK; Ramanathan M
J Comput Aided Mol Des; 2020 Jun; 34(6):671-682. PubMed ID: 32040807
[TBL] [Abstract][Full Text] [Related]
14. Carbamate JNK3 Inhibitors Show Promise as Effective Treatments for Alzheimer's Disease: In Vivo Studies on Mouse Models.
Jun J; Moon H; Yang S; Lee J; Baek J; Kim H; Cho H; Hwang K; Ahn S; Kim Y; Kim G; Kim H; Kwon H; Hah JM
J Med Chem; 2023 May; 66(9):6372-6390. PubMed ID: 37094094
[TBL] [Abstract][Full Text] [Related]
15. Identification of Potential JNK3 Inhibitors: A Combined Approach Using Molecular Docking and Deep Learning-Based Virtual Screening.
Yao C; Shen Z; Shen L; Kadier K; Zhao J; Guo Y; Xu L; Cao J; Dong X; Yang B
Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895928
[TBL] [Abstract][Full Text] [Related]
16. The structure-based optimization of 3-substituted indolin-2-one derivatives as potent and isoform-selective c-Jun N-terminal kinase 3 (JNK3) inhibitors and biological evaluation.
Li Z; Zhu G; Liu X; Gao T; Fang F; Dou X; Li Y; Zheng R; Jin H; Zhang L; Liu Z; Zhang L
Eur J Med Chem; 2023 Mar; 250():115167. PubMed ID: 36764123
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of trizole-based heteroaromatic derivatives as Bcr-Abl kinase inhibitors.
Pan X; Liu N; Liu Y; Zhang Q; Wang K; Liu X; Zhang J
Eur J Med Chem; 2022 Aug; 238():114425. PubMed ID: 35561654
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of a new series of pyrazole derivatives: Discovery of potent and selective JNK3 kinase inhibitors.
Abu Rabah RR; Sebastian A; Vunnam S; Sultan S; Tarazi H; Anbar HS; Shehata MK; Zaraei SO; Elgendy SM; Al Shamma SA; Omar HA; Al-Tel TH; El-Gamal MI
Bioorg Med Chem; 2022 Sep; 69():116894. PubMed ID: 35764033
[TBL] [Abstract][Full Text] [Related]
19. MiR-335-5p Inhibits β-Amyloid (Aβ) Accumulation to Attenuate Cognitive Deficits Through Targeting c-jun-N-terminal Kinase 3 in Alzheimer's Disease.
Wang D; Fei Z; Luo S; Wang H
Curr Neurovasc Res; 2020; 17(1):93-101. PubMed ID: 32003672
[TBL] [Abstract][Full Text] [Related]
20. Identifying New Ligands for JNK3 by Fluorescence Thermal Shift Assays and Native Mass Spectrometry.
Cheng C; Liu M; Gao X; Wu D; Pu M; Ma J; Quinn RJ; Xiao Z; Liu Z
ACS Omega; 2022 Apr; 7(16):13925-13931. PubMed ID: 35559183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
